European Journal of Rheumatology
Letter to the Editor

Combining secukinumab and apremilast to successfully treat refractory psoriatic skin and joint disease: A novel approach

1.

Department of Rheumatology, Luton & Dunstable University Hospital, Luton, United Kingdom

Eur J Rheumatol 2019; 6: 60-61
DOI: 10.5152/eurjrheum.2018.17188
Read: 2489 Downloads: 1140 Published: 03 September 2019

Abstract

 

Cite this article as: Nisar MK. Combining secukinumab and apremilast to successfully treat refractory psoriatic skin and joint disease: a novel approach. Eur J Rheumatol 2019; 6(1): 57-8.

Files
EISSN 2148-4279